Product Information
MOMETASONE FUROATE 0.1% SOLN is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.4951 per ML under NDC 45802011859. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 6, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802011859
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA077180FDA Approved
4/6/2005
TE Code
AB
On Market Since
12/11/2008
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% SOLN has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 39.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4951 per ML |
|---|---|
| All-time high | $0.5133 (Dec 10, 2025) |
| All-time low | $0.2127 (May 17, 2017) |
| 52-week high | $0.5133 |
| 52-week low | $0.4335 |
| Median price | $0.3691 |
| Average price | $0.3566 |
| Largest weekly change | +33.6% (Nov 19, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% SOLN?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% SOLN, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.4951 per ML (NDC 45802011859), effective Aug 19, 2026.
How has the price of MOMETASONE FUROATE 0.1% SOLN changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% SOLN has risen 39.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% SOLN?
Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% SOLN has ranged from a low of $0.2127 (May 17, 2017) to a high of $0.5133 (Dec 10, 2025), with a median of $0.3691 per ML.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% SOLN?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% SOLN, is $0.3672 per ML — about 26% below MOMETASONE FUROATE 0.1% SOLN.
Who manufactures MOMETASONE FUROATE 0.1% SOLN?
MOMETASONE FUROATE 0.1% SOLN (NDC 45802011859) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.